STRATEC Biomedical (SBS) Ratios

6 Followers

STRATEC Biomedical Ratios

DE:SBS's free cash flow for Q4 2025 was €0.25. For the 2025 fiscal year, DE:SBS's free cash flow was decreased by € and operating cash flow was €>-0.01. See a summary of the company’s cash flow.

Ratios	TTM	Mar 26	Mar 25	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	―	3.97	2.47	2.57	3.51
Quick Ratio	―	1.86	1.17	1.09	1.56
Cash Ratio	―	0.43	0.52	0.35	0.38
Solvency Ratio	―	0.09	0.18	0.14	0.27
Operating Cash Flow Ratio	―	>-0.01	0.54	0.20	0.17
Short-Term Operating Cash Flow Coverage	―	-0.02	1.17	0.44	2.09
Net Current Asset Value	€ ―	€ 7.34M	€ 20.98M	€ 14.72M	€ 39.07M
Leverage Ratios
Debt-to-Assets Ratio	―	0.30	0.29	0.30	0.22
Debt-to-Equity Ratio	―	0.56	0.54	0.61	0.39
Debt-to-Capital Ratio	―	0.36	0.35	0.38	0.28
Long-Term Debt-to-Capital Ratio	―	0.29	0.23	0.26	0.23
Financial Leverage Ratio	―	1.87	1.84	2.00	1.77
Debt Service Coverage Ratio	―	0.77	0.87	0.77	7.41
Interest Coverage Ratio	―	2.13	4.89	7.21	27.81
Debt to Market Cap	―	0.45	0.32	0.23	0.07
Interest Debt Per Share	―	11.20	11.21	11.95	7.31
Net Debt to EBITDA	―	4.01	1.76	2.50	1.12
Profitability Margins
Gross Profit Margin	―	25.60%	29.65%	25.21%	28.94%
EBIT Margin	―	3.43%	10.83%	9.44%	14.78%
EBITDA Margin	―	10.84%	18.38%	15.96%	20.95%
Operating Profit Margin	―	3.43%	10.94%	10.40%	15.29%
Pretax Profit Margin	―	1.93%	8.54%	7.97%	14.23%
Net Profit Margin	―	-0.10%	6.22%	5.68%	10.64%
Continuous Operations Profit Margin	―	-0.10%	6.22%	5.68%	10.64%
Net Income Per EBT	―	-4.99%	72.80%	71.34%	74.76%
EBT Per EBIT	―	56.40%	78.09%	76.61%	93.07%
Return on Assets (ROA)	―	-0.05%	3.60%	3.29%	7.35%
Return on Equity (ROE)	―	-0.10%	6.61%	6.59%	12.98%
Return on Capital Employed (ROCE)	―	2.21%	7.95%	7.60%	12.45%
Return on Invested Capital (ROIC)	―	-0.10%	5.13%	4.64%	9.12%
Return on Tangible Assets	―	-0.07%	4.84%	4.35%	9.45%
Earnings Yield	―	-0.09%	4.42%	2.78%	2.97%
Efficiency Ratios
Receivables Turnover	―	3.43	5.97	3.72	4.72
Payables Turnover	―	14.77	9.82	9.43	17.96
Inventory Turnover	―	1.65	1.54	1.42	1.66
Fixed Asset Turnover	―	3.27	3.21	3.22	3.71
Asset Turnover	―	0.57	0.58	0.58	0.69
Working Capital Turnover Ratio	―	1.71	1.81	1.79	1.87
Cash Conversion Cycle	―	302.92	260.91	316.72	277.01
Days of Sales Outstanding	―	106.29	61.18	98.04	77.31
Days of Inventory Outstanding	―	221.35	236.89	257.39	220.03
Days of Payables Outstanding	―	24.71	37.15	38.72	20.32
Operating Cycle	―	327.63	298.06	355.44	297.34
Cash Flow Ratios
Operating Cash Flow Per Share	―	-0.04	4.01	1.60	0.85
Free Cash Flow Per Share	―	-0.80	2.51	0.16	-0.72
CapEx Per Share	―	0.76	1.50	1.43	1.57
Free Cash Flow to Operating Cash Flow	―	22.43	0.63	0.10	-0.85
Dividend Paid and CapEx Coverage Ratio	―	-0.03	1.96	0.66	0.34
Capital Expenditure Coverage Ratio	―	-0.05	2.68	1.11	0.54
Operating Cash Flow Coverage Ratio	―	>-0.01	0.37	0.14	0.12
Operating Cash Flow to Sales Ratio	―	>-0.01	0.19	0.07	0.04
Free Cash Flow Yield	―	-3.56%	8.43%	0.36%	-0.89%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-1.13K	22.61	36.03	33.67
Price-to-Sales (P/S) Ratio	―	1.09	1.41	2.05	3.58
Price-to-Book (P/B) Ratio	―	1.15	1.49	2.37	4.37
Price-to-Free Cash Flow (P/FCF) Ratio	―	-28.10	11.87	276.71	-112.57
Price-to-Operating Cash Flow Ratio	―	-630.26	7.44	28.50	95.72
Price-to-Earnings Growth (PEG) Ratio	―	11.11	4.75	-0.75	-1.25
Price-to-Fair Value	―	1.15	1.49	2.37	4.37
Enterprise Value Multiple	―	14.05	9.41	15.33	18.22
Enterprise Value	―	381.98M	445.62M	661.54M	1.05B
EV to EBITDA	―	14.05	9.41	15.33	18.22
EV to Sales	―	1.52	1.73	2.45	3.82
EV to Free Cash Flow	―	-39.33	14.60	330.61	-119.95
EV to Operating Cash Flow	―	-882.16	9.15	34.06	101.99
Tangible Book Value Per Share	―	10.64	10.58	9.87	11.29
Shareholders’ Equity Per Share	―	19.52	19.95	19.19	18.56
Tax and Other Ratios
Effective Tax Rate	―	1.05	0.27	0.29	0.25
Revenue Per Share	―	20.64	21.19	22.25	22.64
Net Income Per Share	―	-0.02	1.32	1.26	2.41
Tax Burden	―	-0.05	0.73	0.71	0.75
Interest Burden	―	0.56	0.79	0.84	0.96
Research & Development to Revenue	―	0.07	0.05	0.03	0.03
SG&A to Revenue	―	0.15	0.14	0.07	0.07
Stock-Based Compensation to Revenue	―	0.00	0.00	<0.01	<0.01
Income Quality	―	1.79	3.04	1.49	0.35

Currency in EUR